Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial-Reference-Cited by-同舟云学术

Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trial

Published:2020-01-17 Issue:6 Volume:16 Page:1464-1470
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Valéa Innocent¹²,Adjei Samuel³,Usuf Effua⁴^ORCID,Traore Ousmane¹,Ansong Daniel³,Tinto Halidou¹,Owusu Boateng Harry³,Some Athanase Mwinessobaonfou¹,Buabeng Patrick³,Vekemans Johan⁴,Kotey Amos³,Vandoolaeghe Pascale⁴,Cullinane Mark⁴,Traskine Magali⁴,Ouedraogo Florence¹,Sambian David³,Lievens Marc⁴,Tahita Marc Christian¹,Jongert Erik⁴,Lompo Palpouguini¹,Idriss Ali³,Borys Dorota⁴,Ouedraogo Sayouba¹,Prempeh Frank³,Schuerman Lode⁴,Sorgho Hermann¹,Agbenyega Tsiri³

Affiliation:

1. Unité de Recherche Clinique de Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso

2. IRSS, Centre Muraz, Bobo-Dioulasso, Burkina Faso

3. School of Medical Sciences, KNUST (Agogo Presbyterian Hospital), Kumasi, Ghana

4. Vaccine, GSK, Wavre, Belgium

Funder

GlaxoSmithKline Biologicals SA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1695457

Reference14 articles.

1. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Assessment Report: MosquirixTM. [Accessed 2018 Nov 5]. http://bit.ly/2paE1uw.

2. World Health Organization. Hepatitis B. Key facts; July 2019 [Accessed 2019 Jul 12]. https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b.

3. World Health Organization. WHO position paper on hepatitis B vaccines. Weekly epidemiological record No. 40. 2009; 84:405–20. [Accessed Apr 2019]. https://www.who.int/wer/2009/wer8440.pdf?ua=1.

4. Safety and efficacy of the RTS,S/AS01 E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

5. A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomised trial of malaria vaccine R21/Matrix-M™ with and without antimalarial drugs in Thai adults;npj Vaccines;2024-07-06

2. In-silico analysis of potent Mosquirix vaccine adjuvant leads;Journal of Genetic Engineering and Biotechnology;2023-12

3. Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants;npj Vaccines;2021-05-21

4. Online Supplements;Plotkin's Vaccines;2021

5. Pre-Erythrocytic Vaccines against Malaria;Vaccines;2020-07-21